Bausch Health Companies Inc (BHC)

[Zilla]

Things are turning around...
"Mizuho analyst Irina Koffler says her improved outlook (NEUTRAL/$15) on Valeant Pharmaceuticals (NYSE:VRX) is due to the elimination of "near-term sell catalysts" and a realistic 2018 forecast"
200 DMA 16.48
100 DMA 18.33
50 DMA 17
I think we start testing these before ER.
Currently VRX is 15.44
RSI 42.52
CMF -0.043 about to go green after being mostly red since our 52 week high.
Our 52 week low of 8.31 will be moving higher this month as the first wave started in April 2017. I honestly thought we'd fill the gap from ER before that wave around 12 bucks but now I'm thinking were about to go 'off to the races' things seem different, but that doesn't mean we don't keep going down. I'm just thinking it's GO time.